Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS (Severe Acute Respiratory Syndrome)”

724 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 724 results

Not applicableStudy completedNCT04958889
What this trial is testing

COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIV

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2)HIV
Johns Hopkins University 392
Very early researchUnknownNCT04565197
What this trial is testing

Convalescent Plasma Therapy for COVID-19 Patients

Who this might be right for
SARS-CoV Infection
Lahore General Hospital 20
Large-scale testing (Phase 3)Study completedNCT04629703
What this trial is testing

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

Who this might be right for
Covid19SARS (Severe Acute Respiratory Syndrome)SARS Pneumonia+3 more
Rigel Pharmaceuticals 280
Not applicableStudy completedNCT04402879
What this trial is testing

CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2COVID-19Acute Respiratory Distress Syndrome+2 more
University of Calgary 596
Testing effectiveness (Phase 2)Study completedNCT04426695
What this trial is testing

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19

Who this might be right for
COVID-19
Regeneron Pharmaceuticals 2,252
Early research (Phase 1)Ended earlyNCT04866069
What this trial is testing

Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults

Who this might be right for
Covid19
Osman ERGANIS, PhD, Prof 50
Large-scale testing (Phase 3)Study completedNCT04590586
What this trial is testing

Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients

Who this might be right for
COVID-19
Amgen 515
Testing effectiveness (Phase 2)Study completedNCT04569877
What this trial is testing

GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia

Who this might be right for
Severe Acute Respiratory Syndrome (SARS) PneumoniaCOVID-19 Pneumonia
University of Giessen 63
Large-scale testing (Phase 3)Study completedNCT05047601
What this trial is testing

A Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

Who this might be right for
COVID-19
Pfizer 2,954
Early research (Phase 1)Study completedNCT05923424
What this trial is testing

A Trial to Learn if Different Doses of REGN17092 Are Safe in Healthy Adults

Who this might be right for
Healthy Volunteers
Regeneron Pharmaceuticals 40
Not applicableStudy completedNCT04673279
What this trial is testing

Long-term COVID-19 Immune Response in a Vulnerable Neighbourhood in Argentina

Who this might be right for
Coronavirus Disease 2019
Hospital Italiano de Buenos Aires 189
Not applicableStudy completedNCT04468035
What this trial is testing

Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS on COVID-19 Pneumonia Requiring Mechanical Ventilation

Who this might be right for
Covid19
Fondation Hôpital Saint-Joseph 22
Testing effectiveness (Phase 2)Ended earlyNCT04391309
What this trial is testing

COVID-19 and Anti-CD14 Treatment Trial

Who this might be right for
Coronavirus Disease 2019 (COVID-19)Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
National Institute of Allergy and Infectious Diseases (NIAID) 49
Large-scale testing (Phase 3)UnknownNCT04343963
What this trial is testing

Pyridostigmine in Severe SARS-CoV-2 Infection

Who this might be right for
COVID-19SARS-CoV-2
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 436
Testing effectiveness (Phase 2)WithdrawnNCT05018975
What this trial is testing

Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeCytokine Release Syndrome
Loma Linda University
Not applicableStudy completedNCT04403932
What this trial is testing

Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Hospital San Carlos, Madrid 300
Early research (Phase 1)Study completedNCT05339334
What this trial is testing

Learn About the Study Medicine PF-07321332 and Ritonavir in Adult Healthy Chinese Participants.

Who this might be right for
Healthy Participants
Pfizer 14
Large-scale testing (Phase 3)UnknownNCT05182515
What this trial is testing

Plasma Exchange in Covid-19 Patients With Anti-interferon Autoantibodies

Who this might be right for
COVID-19
Centre Hospitalier St Anne 50
Post-approval studies (Phase 4)Study completedNCT04326920
What this trial is testing

Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)

Who this might be right for
COVID-19
University Hospital, Ghent 87
Large-scale testing (Phase 3)Study completedNCT06409663
What this trial is testing

A Strain Change Study for SARS-CoV-2 rS Vaccines

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Novavax 60
Load More Results